Metronomic chemotherapy in pediatric oncology: hype or hope?

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F09%3A%230000837" target="_blank" >RIV/65269705:_____/09:#0000837 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

francouzština

Original language name

Chimiotherapie metronomique en oncologie pediatrique : effet de mode ou espoir reel ?

Original language description

Angiogenesis is crucial for the growth of cancer. As such, it has become an established target in fighting cancer. Metronomic chemotherapy-the chronic administration of chemotherapy at relatively low, minimally toxic doses on a frequent schedule of administration at close regular intervals, with no prolonged drug-free breaks-is a potential novel approach to controlling advanced cancer disease. It is thought to work primarily through antiangiogenic mechanisms and has the property of killing resistant cancer cells while significantly reducing undesirable toxic side effects. We review the data regarding the use of metronomic chemotherapy in children with cancer and discuss its potential uses and limits.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2009

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Archives de Pediatrie

ISSN

0929-693X

e-ISSN

—

Volume of the periodical

16

Issue of the periodical within the volume

8

Country of publishing house

FR - FRANCE

Number of pages

8

Pages from-to

—

UT code for WoS article

—

EID of the result in the Scopus database

—